156479-47-9

Upstream product

• 156479-45-7 (3S,4S,5S)-4-acetoxy-6-benzyloxymethoxy-3-ethyl-5-methylhex-1-ene 
• 156479-43-5 (2S,3S,4R)-1-benzyloxymethoxy-2-methyl-4-(4-methylphenylsulfonyloxymethyl)hex-5-en-3-ol 
• 156479-44-6 (3R,4S,5S)-4-acetoxy-6-benzyloxymethoxy-5-methyl-3-(4-methylphenylsulfonyloxymethyl)hex-1-ene 
• 156479-42-4 (2R,3S,4S)-5-benzyloxymethoxy-4-methyl-2-vinylpentane-1,3-diol 
• 156557-41-4 (4S)-5-benzyloxymethyloxy-2,3-epoxy-4-methylpentan-1-ol 

Downstream Products

• 156479-49-1 (2S,3R,4R)-2-ethyl-1,3-isopropylidenedioxy-4-methyl-5-phenylthiopentane 
• 153977-33-4 (2S)-2-<(4S,5S)-5-Ethyl-2,2-dimethyl-1,2-dioxan-4-yl>-1-tosyloxypropane 
• 144534-91-8 (2S,3R,4R)-2-ethyl-1,3-isopropylidenedioxy-4-methyl-5-phenylsulfinylpentane 
• 131967-58-3 (2S)-2-<(4S,5S)-5-Ethyl-2,2-dimethyl-1,3-dioxan-4-yl>propyl phenyl sulfone 
• 156479-48-0 (2S,3S,4S)-1-benzyloxymethoxy-4-ethyl-3,5-isopropylidenedioxy-2-methylpentane 

Relevant academic research and scientific papers

Stereoselective synthesis of optically active 4-ethyl-3,5-dihydroxy-2- methylpentyl derivatives. A basic building block with three contiguous chiral centers of polyether antibiotics

Optically active 4-ethyl-3,5-dihydroxy-2-methylpentyl derivatives, the iodide (4), phenyl sulfone (5), and phenyl sulfoxide (6), which are chiral synthons for an essential structural unit of polyether antibiotics, were stereoselectively synthesized starti